Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?

Hepatology

Volumn 30, Issue 4, 1999, Pages 865-869

  Krzeski, Piotr ^a   Zych, Wlodzimierz ^a   Kraszewska, Ewa ^a   Milewski, Bohdan ^b   Butruk, Eugeniusz ^a   Habior, Andrzej ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b NATIONAL FOOD AND NUTRITION INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLAND; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL RATE; TIME; VALIDATION PROCESS;

BILIRUBIN; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0032862726     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300415     Document Type: Article

References (30)

1. Benhamou J-P. Indication for liver transplantation in primary biliary cirrhosis. HEPATOLOGY 1994;20(Suppl):11S-13S.
2. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1-7.
3. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, et al. Beneficial effects of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 1985;89:1084-1091.
4. Inoue K, Hirohara J, Nakano T, Sasaki H, Higuchi K, Ohta Y, Onji M., et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995;15:70-77.
5. Kim RW, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. HEPATOLOGY 1998;28:33-38.
6. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. HEPATOLOGY 1989;10:1-7.
7. Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. HEPATOLOGY 1989;10:846-850.
8. van Dam GM, Verbaan BW, Therneau TM, Dickson ER, Malinchoc M, Murtaugh PA, Huizenga JR, et al. Primary biliary cirrhosis: Dutch application of the Mayo model before and after orthotopic liver transplantation. Hepato-Gastroenterology 1997;44:732-743.
9. Moreno Sanchez D, Cassinello OC, Medina AJ, Castilla CV, Castellano TG, Solis HJA. The prognostic factors and evolution of the quality of life in primary biliary cirrhosis. Med Clin Bare 1990;95:490-494.
10. Klion FM, Fabry TL, Palmer M, Schaffner E Prediction of survival of patients with primary biliary cirrhosis. Gastroenterology 1992;102:310-313.
11. Murtaugh PA, Dickson ER, van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. HEPATOLOGY 1994; 20:126-134.
12. Habior A, Krzeski P, Gugulski A, Milewski B. Primary biliary cirrhosis in Poland. Gastroenterol Pol 1994;1:133-137.
13. Krzeski P, Habior A, Zych W. Survival model for Polish patients with primary biliary cirrhosis [Abstract]. Gastroenterol Pol 1996;3:W35.
14. Woolson RE Rank tests and a one-sample logrank test for comparing observed survival data to a standard population. Biometrics 1981;37:687-696.
15. Kaplan EL, Meier P. Nonparamteric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
16. Cox DR. Regression models and life-table (with discussion). J R Stat Soc (B) 1972;34:187-202.
17. Survival Analysis. In: Microsoft Statistica. Statistics II. Tulsa, OK: Statsoft, 1995:3485-3538.
18. Cox DR, Oakes D. Analysis of survival data. First Ed. London: Chapman and Hall, 1984.
19. Schoenfeld D. Partial residuals for proportional hazards regression model. Biometrika 1982;69:239-241.
20. Therneau MT, Grambsch PH. Martingale-based residuals for survival models. Biometrika 1990;77:147-160.
21. Lin DY, Fleming TR, Wei LJ. Confidence bands for survival curves under proportional hazards model. Biometrika 1994;81:73-81.
22. Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
23. Poupon RE, Lindor KD, Dudek KC, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.
24. Altman DG, de Stavola BL. Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat Med 1994;13:301-341.
25. Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterology 1993;105:1865-1876.
26. Bailey EL, Harper TA, Pinkerton PH. The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations. CMAJ 1971;105:1041-1043.
27. Bonnand A-M, Heathcote EJ, Lindor KD, Poupon RE. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. HEPATOLOGY 1999;29:39-43.
28. Shapiro JM, Smith H, Schaffner E Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979;20:137-140.
29. Christensen E. Prognostic models in chronic liver disease: validity, usefulness and future role. J Hepatol 1997;26:1414-1424.
30. Krzeski P, Habior A, Zych W, Kraszewska E, Milewski B. Survival model for Polish population with primary biliary cirrhosis (in Polish). Gastroenterol Pol 1998;5:355-361.